Found 9 matching trials
Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations PHASE1 This phase I clinical trial studies vemurafenib with sorafenib tosylate or ...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer N/A Although several clinical trials provide evidence for efficacy benefit for ...
Show More Location
Hunan Cancer Hospital
Learn More & Join Trial
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer PHASE1 This first-in-human (FIH) study for BNT116 aims to establish the safety pro...
Show More Location
University of Kentucky Chandler Medical Center
Learn More & Join Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) PHASE2 This phase II Pediatric MATCH screening and multi-sub-trial studies how wel...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial
Efficacy and Safety of Precision Therapy in Refractory Tumor PHASE2 This study is intended to evaluate efficacy and safety of targeted precisio...
Show More Location
Shanghai Changzheng Hospital
Learn More & Join Trial
Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies NA In this study, patients who are taking oral tyrosine kinase inhibitor (TKI)...
Show More Status
Active Not Recruiting
Location
University of Virginia
Learn More & Join Trial
Prospective Study on Resistance-associated Mutations in Metastatic Lung Cancer N/A This single-centre prospective study is aimed at analysing, by means of liq...
Show More Location
Fondazione IRCCS San Gerardo dei Tintori
Learn More & Join Trial
A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors. PHASE2 This trial is a multicenter, open-label, biology driven, phase II study usi...
Show More Location
INSTITUT DE CANCEROLOGIE DE L'OUEST Pays de Loire
Learn More & Join Trial
PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC PHASE2 The goal of this Phase II clinical trial (The PHOENIX Study) is to evaluate...
Show More Location
Multiple Locations
Learn More & Join Trial